Pulmonary Disorders create havoc and life threatening effects to lungs. They are mediated by combination of allergic and inflammatory events involving signaling of various cytokines and chemokines, which on further alleviates chain like cascades of multiple inflammatory pathways. Biologics are a modern trend in era of therapeutics owing to their specificity, less adverse events and off target side effects. Monoclonal antibodies are on huge demand in treating various cancers, autoimmune diseases and various inflammatory disorders. New inventions like Bispecific antibodies which targets two different epitopes or allergen simultaneously offers new hopes in mitigating the therapeutic effect. Curiously, I am involved in respiratory pharmacology and working in determining efficacy, potency and safety of BispekDab and enumerate its therapeutic effects against pre clinical in-vivo asthma model (rodents). It involves establishing model standardization by inducing and sensitizing airways along with measurement of Various Lung Functional parameters.Actively seeking new opportunities in the dynamic field of Preclinical and clinical studies to contribute my expertise, leverage my knowledge, widen my horizon and drive innovation.Let's connect and explore the possibilities at the intersection of pharmaceuticals along with Novel innovations.